Skip to main content

Table 1 Demographics and clinical characteristics of the wrist fracture patients and the control group

From: Is health-related quality of life associated with the risk of low-energy wrist fracture: a case-control study

 

Wrist fracture

Controls

p*

 

n = 181

n = 181

 

Demographics

   

Age (years)

66.9 (9.9)

66.8 (9.1)

0.885

Females

161 (89)

161 (89)

1.000

BMI (kg/m2)

25.4 (4.3)

26.6 (4.3)

0.009

Menarche (years)

13.9 (1.5)

13.6 (1.4)

0.046

Menopause (years)

48.9 (4.4)

49.5 (4.1)

0.228

Education

  

0.029

< 10 years

62 (37)

73 (40)

 

11–13 years

70 (42)

52 (29)

 

> 13 years

36 (21)

55 (31)

 

Co-habiting

95 (53)

118 (66)

0.014

Regular exercise**

134 (74)

132 (73)

0.812

Current smoker

29 (16)

23 (13)

0.380

Clinical characteristics

Heart diseases

56 (31)

62 (34)

0.501

Pulmonary diseases

24 (13)

13 (7)

0.056

Neurological diseases

14 (8)

17 (9)

0.573

Endocrine disorders

14 (8)

20 (11)

0.280

Gastrointestinal disorders

12 (7)

22 (12)

0.072

Urogenital disorders

5 (3)

1 (0.5)

0.100

Inflammatory joint and connective tissue disorders

43 (24)

50 (28)

0.400

Cancer

18 (10)

19 (11)

0.862

Mental disorders

7 (4)

11 (6)

0.333

Mean total score co-morbidity (range 0–6)

1.1 (1.1)

1.1 (1.1)

0.259

Current glucocorticoid treatment

12 (7)

3 (2)

0.044

Current calcium and/or vitamin D treatment

40 (22)

43 (24)

0.708

Current ART

26 (14)

11 (6)

0.009

Osteoporosis***

60 (33)

31 (17)

< 0.001

≥1 fall in the previous year

75 (47)

54 (37)

0.089

Previous fracture(s)

97 (54)

82 (46)

0.153

  1. Continuous variables are presented as mean (SD) and group variables as numbers and (%).
  2. * Chi-squared analysis was used to compare categorical data, and an independent t test was used to compare continuous variables.
  3. Bold p values indicate significant differences between the groups.
  4. ** Exercise more than 30 minutes three times a week.
  5. *** Osteoporosis at the total hip or lumbar spine L2-L4 or both.
  6. BMI, body mass index; ART, anti-resorptive treatment, a specific osteoporosis treatment comprising oestrogens, biphosphonates, or selective oestrogen-receptor modulators.